中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
6期
930-931
,共2页
吴校林%李彬%赵玉勤%朱锐%陶红
吳校林%李彬%趙玉勤%硃銳%陶紅
오교림%리빈%조옥근%주예%도홍
肝肾功能%NT-proBNP%扩张型心肌病
肝腎功能%NT-proBNP%擴張型心肌病
간신공능%NT-proBNP%확장형심기병
Liver and kidney function%NT-proBNP%Dilated cardiomyopathy
目的:探讨入院时肝肾功能与NT-proBNP水平对扩张型心肌病患者预后的影响。方法:114例扩张型心肌病患者为四组,分别是扩张型心肌病伴肝肾功能不全组(A组)26例,伴肝功能不全组(B组)16例,伴肾功能不全组(C组)28例和肝肾功能正常组(D组)44例。首次入院后检测肝肾功能和血浆NT-proBNP浓度;所有患者随访并记录1年内发生的主要不良心血管事件(MACE)。结果:A组患者NT-proBNP水平、恶性心律失常发生率和总死亡率较其他三组均较显著升高(P<0.05);D组患者MACE发生率在四组中最低(P<0.05)。结论:肝肾功能与NT-proBNP可以很好的评估扩张型心肌病患者的预后,指导临床治疗。
目的:探討入院時肝腎功能與NT-proBNP水平對擴張型心肌病患者預後的影響。方法:114例擴張型心肌病患者為四組,分彆是擴張型心肌病伴肝腎功能不全組(A組)26例,伴肝功能不全組(B組)16例,伴腎功能不全組(C組)28例和肝腎功能正常組(D組)44例。首次入院後檢測肝腎功能和血漿NT-proBNP濃度;所有患者隨訪併記錄1年內髮生的主要不良心血管事件(MACE)。結果:A組患者NT-proBNP水平、噁性心律失常髮生率和總死亡率較其他三組均較顯著升高(P<0.05);D組患者MACE髮生率在四組中最低(P<0.05)。結論:肝腎功能與NT-proBNP可以很好的評估擴張型心肌病患者的預後,指導臨床治療。
목적:탐토입원시간신공능여NT-proBNP수평대확장형심기병환자예후적영향。방법:114례확장형심기병환자위사조,분별시확장형심기병반간신공능불전조(A조)26례,반간공능불전조(B조)16례,반신공능불전조(C조)28례화간신공능정상조(D조)44례。수차입원후검측간신공능화혈장NT-proBNP농도;소유환자수방병기록1년내발생적주요불양심혈관사건(MACE)。결과:A조환자NT-proBNP수평、악성심률실상발생솔화총사망솔교기타삼조균교현저승고(P<0.05);D조환자MACE발생솔재사조중최저(P<0.05)。결론:간신공능여NT-proBNP가이흔호적평고확장형심기병환자적예후,지도림상치료。
Objective:To investigate the effects of liver and kidney function and NT-proBNP level on patients with dilated cardiomyopathy. Methods:114 patients with dilated cardiomyopathy were divided into four groups,including dilated cardiomyopathy associated with liver and kidney dysfunction group(group A,n=26),associated with liver dysfunction group(group B,n=16),associated with kidney dysfunction group(group C,n=26) and normal liver and kidney function group(group D,n=26).Liver and kidney function and plasma NT-proBNP concentration were detected after first time adminssion.All patients were followed up and recorded major adverse cardiac events(MACE)occurred in one year.Results:The NT-proBNP level,incidence of malignant arrhythmias and total mortality in groupA were significantly higher than other three groups(P<0.05).The incidence of MACE in group D was lowest in the four groups(P<0.05).Conclusion:Liver and kidney function and NT-proBNP can better assess the prognosis of patients with dilated cardiomyopathy and guide Clinical treatment.